Markets News
Latest stock market news and real-time market analysis. Track S&P 500, Nasdaq, and Dow Jones movements, sector rotations, and breaking market events.
Intel Retreats in Extended Trading as Investors Eye Economic Data, Chip Sector Diverges
Intel shares declined 0.7% in after-hours trading following a volatile session, while rivals Nvidia and AMD advanced. Market focus shifts to upcoming U.S. jobs and inflation reports.
Microsoft Rebounds 3% as Software Stocks Recover from AI Selloff
Microsoft shares gained 3.1% to $413.68, lifting its market cap to $3.59 trillion. The rebound follows a sector-wide pullback, with analysts divided on AI spending and cloud capacity constraints.
Apple Shares Dip in Extended Trading Ahead of Key Economic Data
Apple shares declined 1.3% in after-hours trading Monday, underperforming a broader tech rally as investors await U.S. jobs and inflation reports. The company's annual shareholder meeting is scheduled for February 24.
BlackRock Shares Gain on Deutsche Bank Aladdin Integration and Fund Restructuring
BlackRock's stock rose 2.5% following an FX workflow automation partnership with Deutsche Bank and a consolidation of municipal closed-end funds. Investors await CFO commentary and key economic data.
Seagate Shares Dip Amid Analyst Target Hikes, Macro Data in Focus
Seagate stock declined 0.4% to $427.48 despite Loop Capital raising its price target to $700. Investors await U.S. jobs and inflation data for interest rate signals.
Amgen Shares Slide on FDA Setback and Enbrel Weakness, Pressuring Dow
Amgen stock fell nearly 2% Monday, pressured by an FDA request to withdraw rare-disease drug Tavneos and a sharp 48% quarterly drop in Enbrel sales. The decline weighed on the price-weighted Dow Jones Industrial Average.
Philip Morris Shares Dip Amid Zyn Competition and Debt Filing
Philip Morris International stock declined 1.4% to $180.17 as investors weighed nicotine pouch rivalry and a new debt shelf registration. Several analysts raised price targets following the company's 2026 outlook.
Arrowhead Sees Volatility After S&P MidCap 400 Inclusion, Goldman Eyes 2026 Pipeline
Arrowhead Pharmaceuticals shares experienced heightened trading activity and a slight decline following its transition to the S&P MidCap 400 index. Goldman Sachs reiterated a Neutral stance, highlighting pivotal 2026 clinical data and competitive pressures.
Microchip Technology Shares Slide on $600M Convertible Debt Offering
Microchip Technology shares fell after announcing a $600 million convertible senior notes offering, with proceeds earmarked for hedging and debt repayment. Investors are watching pricing terms and potential dilution.
Amphenol Shares Surge 6% on Insider Purchase and Leadership Transition
Amphenol stock rose over 6% Monday following a director's $1.29 million share purchase and the announcement of CEO R. Adam Norwitt's upcoming appointment as chairman.
Thermo Fisher Files Multi-Tranche Bond Offering to Finance Clario Acquisition
Thermo Fisher Scientific shares edged higher Monday after filing a preliminary prospectus for a four-part senior notes offering to fund its planned Clario acquisition. The company reported consolidated debt of $39.38 billion as of December 31, 2025.